These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34544650)

  • 1. Combination MRI-targeted and systematic prostate biopsy may overestimate gleason grade on final surgical pathology and impact risk stratification.
    Yu A; Yamany T; Mojtahed A; Hanna N; Nicaise E; Harisinghani M; Wu CL; Dahl DM; Wszolek M; Blute ML; Feldman AS
    Urol Oncol; 2022 Feb; 40(2):59.e1-59.e5. PubMed ID: 34544650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical Prostatectomy.
    Yilmaz EC; Lin Y; Belue MJ; Harmon SA; Phelps TE; Merriman KM; Hazen LA; Garcia C; Johnson L; Lay NS; Toubaji A; Merino MJ; Patel KR; Parnes HL; Law YM; Wood BJ; Gurram S; Choyke PL; Pinto PA; Turkbey B
    AJR Am J Roentgenol; 2024 Jan; 222(1):e2329964. PubMed ID: 37729551
    [No Abstract]   [Full Text] [Related]  

  • 3. Gleason Grade Group Concordance between Preoperative Targeted Biopsy and Radical Prostatectomy Histopathologic Analysis: A Comparison Between In-Bore MRI-guided and MRI-Transrectal US Fusion Prostate Biopsies.
    Costa DN; Cai Q; Xi Y; Recchimuzzi DZ; Subramanian N; Bagrodia A; Rofsky NM; Roehrborn CG; Hornberger B; Shah RB; Goldberg K; Diaz de Leon A; Pedrosa I
    Radiol Imaging Cancer; 2021 Mar; 3(2):e200123. PubMed ID: 33817652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy.
    Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M
    BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Biopsy for Quantitative Gleason 4 Grading Prediction in Radical Prostatectomy Specimens: Implications for Active Surveillance Candidate Selection.
    Kachanov M; Budäus L; Beyersdorff D; Karakiewicz PI; Tian Z; Falkenbach F; Tilki D; Maurer T; Sauter G; Graefen M; Leyh-Bannurah SR
    Eur Urol Focus; 2023 Mar; 9(2):303-308. PubMed ID: 36184537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling.
    Luzzago S; Petralia G; Maresca D; Sabatini I; Cordima G; Brescia A; Verweij F; Garelli G; Mistretta FA; Cioffi A; Pricolo P; Alessi S; Ferro M; Matei DV; Renne G; de Cobelli O; Musi G
    Urol Oncol; 2020 Dec; 38(12):929.e11-929.e19. PubMed ID: 32600928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Systematic and MRI-US Fusion Prostate Biopsy Has the Highest Grading Accuracy When Compared to Final Pathology.
    Andras I; Cata ED; Serban A; Kadula P; Telecan T; Buzoianu M; Bungardean M; Stanca DV; Coman I; Crisan N
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34067302
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of Gleason 6 prostate cancer in patients with clinically significant prostate cancer on multiparametric magnetic resonance imaging.
    Chaloupka M; Bischoff R; Pfitzinger P; Lellig E; Ledderose S; Buchner A; Schlenker B; Stief C; Clevert DA; Apfelbeck M
    Clin Hemorheol Microcirc; 2019; 73(1):105-111. PubMed ID: 31561351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen.
    Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA
    Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy.
    Gaffney CD; Tin AL; Fainberg J; Fine S; Jibara G; Touijer K; Eastham J; Scardino P; Laudone V; Vickers AJ; Ehdaie B
    Cancer; 2023 Dec; 129(23):3790-3796. PubMed ID: 37584213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimized grade group for reporting prostate cancer grade in systematic and MRI-targeted biopsies.
    He Y; Shen Q; Fu W; Wang H; Song G
    Prostate; 2022 Aug; 82(11):1125-1132. PubMed ID: 35538399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal Method for Reporting Prostate Cancer Grade in MRI-targeted Biopsies.
    Deng FM; Isaila B; Jones D; Ren Q; Kyung P; Hoskoppal D; Huang H; Mirsadraei L; Xia Y; Melamed J
    Am J Surg Pathol; 2022 Jan; 46(1):44-50. PubMed ID: 34115670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
    Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
    Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
    Siddiqui MM; Rais-Bahrami S; Truong H; Stamatakis L; Vourganti S; Nix J; Hoang AN; Walton-Diaz A; Shuch B; Weintraub M; Kruecker J; Amalou H; Turkbey B; Merino MJ; Choyke PL; Wood BJ; Pinto PA
    Eur Urol; 2013 Nov; 64(5):713-719. PubMed ID: 23787357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.
    Le JD; Stephenson S; Brugger M; Lu DY; Lieu P; Sonn GA; Natarajan S; Dorey FJ; Huang J; Margolis DJ; Reiter RE; Marks LS
    J Urol; 2014 Nov; 192(5):1367-73. PubMed ID: 24793118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
    Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
    BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.
    Wu S; Feldman AS; Kim MM; Lin SX; Cornejo KM; Harisinghani MG; Dahl DM; Wu CL
    Urology; 2023 May; 175():151-156. PubMed ID: 36828261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of adverse pathology at prostatectomy in the era of MRI and targeted biopsies; rethinking active surveillance for intermediate risk prostate cancer patients.
    Bloom JB; Daneshvar MA; Lebastchi AH; Ahdoot M; Gold SA; Hale G; Mehralivand S; Sanford T; Valera V; Wood BJ; Choyke PL; Merino MJ; Turkbey B; Parnes HL; Pinto PA
    Urol Oncol; 2021 Oct; 39(10):729.e1-729.e6. PubMed ID: 33736975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI-ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic-assisted transperineal prostate biopsy platform comparing systematic vs targeted biopsy.
    Lee AYM; Yang XY; Lee HJ; Law YM; Huang HH; Lau WKO; Lee LS; Ho HSS; Tay KJ; Cheng CWS; Yuen JSP; Chen K
    BJU Int; 2020 Nov; 126(5):568-576. PubMed ID: 32438463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.